Medicus Pharma signs non-binding LOI with unnamed SPAC to take SkinJect unit public at $135M pre-money valuation

Medicus Pharma announced a non-binding letter of intent with an unnamed SPAC to take its SkinJect unit public at a $135 million pre-money valuation.

Detected & updated continuously · Source: Nebula